Needle-Free IV Connectors are routinely used in the hospitals for intravenous administration of fluids and medicines to protect the hubs in vascular access systems. In order to reduce risks of possible contaminations associated with the IV administration and to curb manipulation as much as possible, needle free IV connectors can prove to be ideal in all types of IV infusions. Furthermore, technological advancements such as connectors that prevent fluid reflux, highly closed systems, and connectors embedded with antimicrobial agents (V-Link) have helped to decrease the risk of bloodstream infections associated with IV administration. Needle-free connectors are with extended dwell time that can help preventing intraluminal contamination and device cross-contamination, which can be favorable for the growth of the market in the near future.
Get HOLISTIC Request Sample Copy Of This Business Report:
Government organizations and regulatory bodies namely Centers for Disease Control and prevention (CDC) have recommended the usage of needle-free connectors to reduce the incidence of sharp injuries and blood stream infections mandating its usage in medical facilities in the ‘Guidelines for the Prevention of Intravascular Catheter-Related Infections’ in 2011. Major issues associated with the conventional options of intravenous infusion are contamination from external sources during administration, blood reflux, and risk of bloodstream infections, which are addressed by needle-free IV connectors. The National Healthcare Safety Network (NHSN) conducts various programs worldwide that helps to impart education and hands on training sessions to all physicians and nurses about the usage of needle-free connectors and insertion of central venous catheters in children and adults. The advantages of needle-free IV connectors over conventional IV administration namely, safer access to IV lines without using needle, reduced risk of bloodstream infections and reduced possibility of contamination, rising chronic diseases prevalence and cost containment through use of needle-free IV connectors is expected to boost the growth of needle-free IV connectors market over the forecast period.
Some major players operating in the needle-free IV connectors market are Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA.
This report segments the global IV Connectors (Needle-free) market on the basis of design type, mechanism, and dwell time. On the basis of design type, the global needle-free IV connectors market is segmented into Simple and Complex. Mechanisms of needle-free IV connectors include positive, negative, and neutral. Needle-free IV connectors are segmented by dwell time as seven-day dwell time and other than seven-day.
Key features of the study:
This report provides in-depth analysis of needle-free IV connectors and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global Needle-Free IV Connectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Baxter International, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA
According to the World Health Organization (WHO), annually around 1 million deaths are associated with the improper use of syringes and needles, which can be prevented by using needle-free IV connectors. Harmful diseases namely hepatitis and HIV can spread through improper and reuse of needles and syringes. Unsafe use of injections accounts for 5% of HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections globally. Although needle stick injuries are uncommon they are a potential problem, which can prove to be serious and are also responsible for causing above mentioned diseases. According to the Centers for Disease Control and Prevention (CDC), needle stick injuries account for around 385,000 among healthcare workers in the U.S annually. The most important goal while employing IV administration sets and needle-free connectors is to reduce the manipulation factor as much as possible. Some of the U.S. Food & Drug Administration (FDA) approved needle-free IV connectors include One-Link, CARESITE, MaxPlus, and Kendall.
“The global needle-free IV connectors market was valued at US$ 621.1 million in 2016 and is expected to reach a robust CAGR of 10.3% over the forecast period (2017-2025).”
Click To Reading More On Needle-free IV Connectors Market
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154